Correction to: Artificial Intelligence Based on Machine Learning in Pharmacovigilance: A Scoping Review

Benjamin Kompa^{1

2}, Joe B Hakim³, Anil Palepu³, Kathryn Grace Kompa⁴, Michael Smith⁵, Paul A Bain⁶, Stephen Woloszynek⁷, Jeffery L Painter⁸, Andrew Bate^{9

10

11}, Andrew L Beam^{12

13

14}

Affiliations

¹ Department of Biomedical Informatics, Harvard Medical School, Boston, MA, USA.
² CAUSALab, Harvard T.H. Chan School of Public Health, Boston, MA, USA.
³ Department of Health Sciences and Technology, Harvard-MIT, Cambridge, MA, USA.
⁴ Tufts University School of Medicine, Boston, MA, USA.
⁵ Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA.
⁶ Countway Library of Medicine, Harvard Medical School, Boston, MA, USA.
⁷ Beth Israel Deaconess Medical Center, Boston, MA, USA.
⁸ GlaxoSmithKline, Durham, NC, USA.
⁹ GlaxoSmithKline, Brentford, UK.
¹⁰ Department of Non-Communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, University of London, London, UK.
¹¹ Department of Medicine, NYU Grossman School of Medicine, New York, NY, USA.
¹² Department of Biomedical Informatics, Harvard Medical School, Boston, MA, USA. Andrew_Beam@hms.harvard.edu.
¹³ CAUSALab, Harvard T.H. Chan School of Public Health, Boston, MA, USA. Andrew_Beam@hms.harvard.edu.
¹⁴ Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA. Andrew_Beam@hms.harvard.edu.

Published Erratum

Benjamin Kompa et al. Drug Saf. 2023 Apr.

. 2023 Apr;46(4):433.

doi: 10.1007/s40264-023-01273-9.

¹ Department of Biomedical Informatics, Harvard Medical School, Boston, MA, USA.
² CAUSALab, Harvard T.H. Chan School of Public Health, Boston, MA, USA.
³ Department of Health Sciences and Technology, Harvard-MIT, Cambridge, MA, USA.
⁴ Tufts University School of Medicine, Boston, MA, USA.
⁵ Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA.
⁶ Countway Library of Medicine, Harvard Medical School, Boston, MA, USA.
⁷ Beth Israel Deaconess Medical Center, Boston, MA, USA.
⁸ GlaxoSmithKline, Durham, NC, USA.
⁹ GlaxoSmithKline, Brentford, UK.
¹⁰ Department of Non-Communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, University of London, London, UK.
¹¹ Department of Medicine, NYU Grossman School of Medicine, New York, NY, USA.
¹² Department of Biomedical Informatics, Harvard Medical School, Boston, MA, USA. Andrew_Beam@hms.harvard.edu.
¹³ CAUSALab, Harvard T.H. Chan School of Public Health, Boston, MA, USA. Andrew_Beam@hms.harvard.edu.
¹⁴ Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA. Andrew_Beam@hms.harvard.edu.

No abstract available

Erratum for

Artificial Intelligence Based on Machine Learning in Pharmacovigilance: A Scoping Review.
Kompa B, Hakim JB, Palepu A, Kompa KG, Smith M, Bain PA, Woloszynek S, Painter JL, Bate A, Beam AL. Kompa B, et al. Drug Saf. 2022 May;45(5):477-491. doi: 10.1007/s40264-022-01176-1. Epub 2022 May 17. Drug Saf. 2022. PMID: 35579812 Free PMC article.